Entities / Company
Atai Life Sciences.
German pharmaceutical company
- Reports this week
- 0
- Active events
- 1
- Connections
- 36
What's happening
Gone quiet
No new reports in 90+ days-
Atai Life Sciences and Recognify Life Sciences reported on the same clinical trial results on July 28, 2025.Some support3 reports
-
Robert F. Kennedy Jr. discussed the potential benefits of psychedelic medicines, mentioning Atai Life Sciences.Speculative1 report
-
Apeiron Investment Group Limited became the largest shareholder of Atai Life Sciences on July 3, 2025.Speculative2 reports
-
Atai Life Sciences and Beckley Psytech Limited announced encouraging Phase 2b trial results and plans to engage the FDA regarding Phase 3 trial design.Speculative2 reports
-
Both Atai Life Sciences and IDEXX Laboratories, Inc. are performing well in the Medical sector.Some support2 reports
-
Atai Life Sciences and Beckley Psytech announced a strategic combination to solidify global leadership.Some support2 reports
-
Oppenheimer rated Atai Life Sciences as 'Outperform' on August 20, 2025.Some support1 report
-
Atai Life Sciences used LinkedIn for updates and participated in a TD Cowen summit.Some support1 report
-
Atai Life Sciences plans an End-of-Phase 2 meeting request and strategic merger, while tariffs benefit certain AI stocks.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Atai Life Sciences this week
News at the entities that move Atai Life Sciences most-
FDA StructuralGeneric medicine services are seeking approval for launch from the FDA.Moves Atai Life Sciences
-
TD Cowen TransactionalAnalyst downgraded Ag Growth International Inc. due to debt management risks.Moves Atai Life Sciences
-
Incepta Pharmaceuticals Shared contextTilray Brands, Inc.'s stock change lagged the S&P 500 gain on August 28, 2025, while the company holds a Zacks Rank of #3.Moves Atai Life Sciences
-
Berlin Shared contextLinton, an artist, is performing in residences in Cambridge and Hanoi, while working and living in Berlin, and maintains a professional presence on Instagram.Moves Atai Life Sciences
Connections
The 5 strongest of 36, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Srinivas Rao Structural
Srinivas Rao serves as the CEO and Co-founder of Atai Life Sciences.
-
FDA Structural
Atai Life Sciences actively seeks regulatory guidance and approval from the FDA regarding its clinical trial designs and filings.
-
TD Cowen Transactional
TD Cowen facilitated a placement role for Atai Life Sciences and hosted a summit Atai participated in.
-
Incepta Pharmaceuticals Shared context
Atai Life Sciences and Incepta Pharmaceuticals share the same pharmaceutical industry context.
-
Berlin Shared context
Atai Life Sciences operates from Berlin, establishing a shared geographical context.
History
Events by the month they beganJune 2026
10 events- Atai Life Sciences, a German-headquartered company, is seeking FDA meetings and study results while benefiting from Trump-era tariffs.
- Atai Life Sciences and Recognify Life Sciences reported on the same clinical trial results on July 28, 2025.
- Robert F. Kennedy Jr. discussed the potential benefits of psychedelic medicines, mentioning Atai Life Sciences.
- Apeiron Investment Group Limited became the largest shareholder of Atai Life Sciences on July 3, 2025.
- Atai Life Sciences and Beckley Psytech Limited announced encouraging Phase 2b trial results and plans to engage the FDA regarding Phase 3 trial design.
- Both Atai Life Sciences and IDEXX Laboratories, Inc. are performing well in the Medical sector.
- Atai Life Sciences and Beckley Psytech announced a strategic combination to solidify global leadership.
- Oppenheimer rated Atai Life Sciences as 'Outperform' on August 20, 2025.
- Atai Life Sciences used LinkedIn for updates and participated in a TD Cowen summit.
- Atai Life Sciences plans an End-of-Phase 2 meeting request and strategic merger, while tariffs benefit certain AI stocks.